Inquis Medical Announces $75 Million Series C Financing to Scale Commercial Adoption of its AVENTUS Thrombectomy System
Inquis Medical, Inc., a privately held medical technology company dedicated to advancing mechanical thrombectomy for venous thromboembolic disease (“VTE”), today announced the closing of a $75 million Series C financing round. The investment, provided by an undisclosed strategic investor, will be used to accelerate nationwide commercial expansion of the AVENTUS™ Thrombectomy System and advance the company’s next-generation product pipeline.
